Multimarker risk strategy for predicting 1-month and 1-year major events in non–ST-elevation acute coronary syndromes
Open Access
- 1 February 2005
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 149 (2), 268-274
- https://doi.org/10.1016/j.ahj.2004.05.053
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Usefulness of concomitant myoglobin and troponin elevation as a biochemical marker of mortality in non–ST-segment elevation acute coronary syndromesThe American Journal of Cardiology, 2003
- The prognostic value of serum myoglobin in patients with non–ST-segment elevation acute coronary syndromes: Results from the TIMI 11B and TACTICS-TIMI 18 studiesJournal of the American College of Cardiology, 2002
- Inflammation and Long-Term Mortality After Non–ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive PatientsCirculation, 2002
- Cardiac Biomarkers for Rapid Evaluation of Chest PainCirculation, 2001
- The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysisJournal of the American College of Cardiology, 2001
- Implications of troponin testing in clinical medicineTrials, 2001
- Inflammatory Markers of Coronary RiskNew England Journal of Medicine, 2000
- Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Independent Prognostic Value of Elevated C-Reactive Protein in Unstable AnginaCirculation, 1999
- Prognostic Influence of Increased Fibrinogen and C-Reactive Protein Levels in Unstable Coronary Artery DiseaseCirculation, 1997